Extension of Time to File SOU

LIVMARLI

Mirum Pharmaceuticals, Inc.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88857240
LAW OFFICE ASSIGNED LAW OFFICE 112
MARK SECTION
MARK LIVMARLI (see, http://uspto.report/TM/88857240/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT LIVMARLI
OWNER SECTION (current)
NAME Mirum Pharmaceuticals, Inc.
MAILING ADDRESS 950 Tower Lane, Suite 1050
CITY Foster City
STATE California
ZIP/POSTAL CODE 94404
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME Mirum Pharmaceuticals, Inc.
MAILING ADDRESS 950 Tower Lane, Suite 1050
CITY Foster City
STATE California
ZIP/POSTAL CODE 94404
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Karl M. Zielaznicki, Esq.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@troutman.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) Karl.Zielaznicki@troutman.com; Eliza.Cen@troutman.com
DOCKET/REFERENCE NUMBER 254409000397
CORRESPONDENCE INFORMATION (proposed)
NAME Karl M. Zielaznicki, Esq.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@troutman.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) Karl.Zielaznicki@troutman.com; Eliza.Cen@troutman.com
DOCKET/REFERENCE NUMBER 254409000397
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations for the treatment of liver disease
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 2
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 09/22/2020
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /kmz/
SIGNATORY'S NAME Karl M. Zielaznicki
SIGNATORY'S POSITION Attorney of record, New York bar member
DATE SIGNED 07/26/2021
SIGNATORY'S PHONE NUMBER 212.704.6125
SIGNATURE METHOD Signed directly within the form
FILING INFORMATION
SUBMIT DATE Mon Jul 26 13:33:40 ET 2021
TEAS STAMP USPTO/ESU-XXX.XX.XX.XX-20
210726133340723173-888572
40-780af6cba8a42ac46611e8
122ea9225a744b8308052b2bf
b38ce8a9f35a247841-DA-333
82921-2021072613322261004
6



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: LIVMARLI (see, http://uspto.report/TM/88857240/mark.png)
SERIAL NUMBER: 88857240

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Mirum Pharmaceuticals, Inc., having an address of
      950 Tower Lane, Suite 1050
      Foster City, California 94404
      United States
      Email: XXXX
Proposed: Mirum Pharmaceuticals, Inc., having an address of
      950 Tower Lane, Suite 1050
      Foster City, California 94404
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 09/22/2020.

For International Class 005:
Current identification: Pharmaceutical preparations for the treatment of liver disease

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Karl M. Zielaznicki, Esq.
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@troutman.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): Karl.Zielaznicki@troutman.com; Eliza.Cen@troutman.com

Correspondence Information (proposed):
      Karl M. Zielaznicki, Esq.
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@troutman.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): Karl.Zielaznicki@troutman.com; Eliza.Cen@troutman.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /kmz/      Date Signed: 07/26/2021
Signatory's Name: Karl M. Zielaznicki
Signatory's Position: Attorney of record, New York bar member
Signatory's Phone: 212.704.6125
Signature method: Signed directly within the form

PAYMENT: 88857240
PAYMENT DATE: 07/26/2021

Serial Number: 88857240
Internet Transmission Date: Mon Jul 26 13:33:40 ET 2021
TEAS Stamp: USPTO/ESU-XXX.XX.XX.XX-20210726133340723
173-88857240-780af6cba8a42ac46611e8122ea
9225a744b8308052b2bfb38ce8a9f35a247841-D
A-33382921-20210726133222610046




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed